Axsome Therapeutics Inc’s filing revealed that its Director Saad Mark E unloaded Company’s shares for reported $1.01 million on Sep 11 ’24. In the deal valued at $91.31 per share,11,016 shares were sold. As a result of this transaction, Saad Mark E now holds 10,002 shares worth roughly $1.13 million.
Then, Saad Mark E bought 11,016 shares, generating $1,005,843 in total proceeds.
Before that, Jacobson Mark L. sold 47,739 shares. Axsome Therapeutics Inc shares valued at $4,022,488 were divested by the Chief Operating Officer at a price of $84.26 per share. As a result of the transaction, Jacobson Mark L. now holds 5,783 shares, worth roughly $0.65 million.
Mizuho reiterated its Axsome Therapeutics Inc [AXSM] rating to an Outperform in a research note published on December 31, 2024; the price target was $122. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in early September with a ‘”an Overweight”‘ rating. BofA Securities also remained covering AXSM and has increased its forecast on August 06, 2024 with a “Buy” recommendation from previously “Neutral” rating. Needham started covering the stock on July 22, 2024. It rated AXSM as “a Buy”.
Price Performance Review of AXSM
On Tuesday, Axsome Therapeutics Inc [NASDAQ:AXSM] saw its stock jump 5.11% to $112.92. Over the last five days, the stock has gained 10.21%. Axsome Therapeutics Inc shares have risen nearly 33.46% since the year began. Nevertheless, the stocks have risen 20.83% over the past one year. While a 52-week high of $111.51 was reached on 02/04/25, a 52-week low of $64.11 was recorded on 01/10/25. SMA at 50 days reached $94.89, while 200 days put it at $86.57.
Levels Of Support And Resistance For AXSM Stock
The 24-hour chart illustrates a support level at 109.50, which if violated will result in even more drops to 106.09. On the upside, there is a resistance level at 114.83. A further resistance level may holdings at 116.75. The Relative Strength Index (RSI) on the 14-day chart is 71.60, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.74, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.50%. Stochastics %K at 88.94% indicates the stock is a selling.
How much short interest is there in Axsome Therapeutics Inc?
A steep rise in short interest was recorded in Axsome Therapeutics Inc stocks on 2025-01-15, dropping by -0.76 million shares to a total of 5.75 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 6.52 million shares. There was a decline of -13.27%, which implies that there is a negative sentiment for the stock.